Sunday 17 May 2020
myNEO will attend job fairs and participate in the following events provided that the Covid-19 regulations will allow for these events to take place:…
read more
Monday 20 September 2021
To allow further growth, myNEO has moved to new offices! You can find us here: Ottergemsesteenweg 439, Ghent. Welcome to come by and visit us!
Tuesday 7 September 2021
Lore Van Oudenhove and Lena Pfitzer, both excellent principal Data Scientists at myNEO, will present their research at the ImmunoTherapy for Cancer C…
Monday 26 July 2021
The partners have received a VLAIO grant to drive innovation in neoantigen identification and validation for personalised T-cell immunotherapy The…
Tuesday 6 July 2021
The entrepreneurship world cup, organised by VOKA and GEN-Global, is an international competition for pre-starters, starters, and scalers. The compet…
Friday 18 June 2021
EIT Health Catapult provides investors and industry representatives an excellent opportunity to gain access to a concentrated elite group of top Euro…
Monday 17 May 2021
In an ongoing collaboration between myNEO and Radboud University Medical Center, novel neoantigens arising from non-coding regions are being investig…
Monday 3 May 2021
myNEO will be present at the 18th CIMT Annual Meeting, Europe's largest specialty meeting on cancer immunotherapy research, translation, and developm…
Wednesday 7 April 2021
Fighting Cancer with Personalised Vaccines: ONCODNA and myNEO collaboration Read the recent press release here in Dutch, French or English. Onc…
Monday 22 March 2021
Join us at Innovation for Health (April 15-16)! Cedric Bogaert will give a presentation in the AI & Digital Health session (10.15am-11.15am) on how …
Thursday 11 March 2021
myNEO announced in May 2020 the identification of promising immunogenic covid-19 peptides by making smart use of its computational algorithms which r…
Tuesday 9 March 2021
myNEO was recently selected as one of the finalists of the Computable Awards 2021 Tech Startup of the Year award. Computable awards selected for t…
Sunday 17 January 2021
Ghent, Belgium, 4 November 2020 – myNEO, a developer of personalised therapeutics using the patient’s tumour-specific alterations, today announced th…
Tuesday 12 January 2021
Multiple reports have revealed that the original strains of SARS-CoV-2 have been divergently mutating into different sub-strains with different chara…
Monday 12 October 2020
myNEO has been selected as one of the five laureates for Belgian scale-up of the year (entrepreneurs on their way to an international breaktrough). …
Monday 7 September 2020
Cedric Bogaert will present the myNEO technology this week at the MedInvest – AI, Big Data and Digital Health conference. He will explain how AI can …
Monday 31 August 2020
myNEO recently affiliated with Amazon via the Amazon AWS activate program, that allows rapidly growing companies to further expand their MVP. This…
Thursday 2 July 2020
myNEO announces that promising Covid-19 peptides have been identified which will undergo further preclinical testing. By making smart use of existing…
Monday 18 May 2020
myNEO and eTheRNA announce a research programme to investigate a promising long non-coding RNA as a source of immunogenic targets for therapeutic use…
Monday 11 May 2020
myNEO collaborates with VUB-LMCT to develop high-throughput assays for immunogenicity validation of predicted SARS-CoV-2 epitopes The aim of the p…